Author:
Qin Lin,Wang Kan,Ou Yang,Pang Long
Abstract
Abstract
Background
Veterinary antiparasitic drugs are widely used in countries and regions in which parasitic diseases are endemic, which leads to the risk of accidental ingestion and poisoning in humans.
Case presentation
A 40-year-old male patient with a history of cirrhosis sought medical attention on November 25, 2021, due to progressive vision loss. He had previously taken triclabendazole and bithionol and was diagnosed with toxic optic neuropathy on examination. Steroid, neurotonic, and high-pressure oxygen therapy were ineffective.
Conclusions
Triclabendazole and bithionol have potential risk of optic neurotoxicity and should be considered for enhanced supervision and warning labels.
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology,General Medicine
Reference14 articles.
1. Ghods S, Khalili Pour E, Riazi-Esfahani H, Faghihi H, Inanloo B. Closantel retinal toxicity: case report and literature review. Case Rep Ophthalmol Med. 2021;2021:1–4.
2. Khalili MR, Zareei A. Case report: restored vision after ocular Closantel intoxication and blindness. BMC Ophthalmol. 2021;21(1):158.
3. Hong ST, Lee SH, Ahn HS, Yun CK. A case of niclofolan (Bilevon(R)) intoxication. Kisaengchunghak Chapchi. 1982;20(1):49–52.
4. Marcos L, Maco V, Terashima A. Triclabendazole for the treatment of human fascioliasis and the threat of treatment failures. Expert Rev Anti-Infe. 2021;19(7):817–23.
5. Gandhi P, Schmitt EK, Chen C, Samantray S, Venishetty VK, Hughes D. Triclabendazole in the treatment of human fascioliasis: a review. T Roy Soc Trop Med H. 2019;113(12):797–804.